510(k) K904312

RHEUMAGEN CRP T-CONTROL by Biokit USA, Inc. — Product Code DCK

K904312 is an FDA 510(k) premarket notification submitted by Biokit USA, Inc. for the device "RHEUMAGEN CRP T-CONTROL". The FDA issued a decision of Substantially Equivalent on October 1, 1990. The device falls under product code DCK (C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270. Biokit USA, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 1, 1990
Date Received
September 19, 1990
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
C-Reactive Protein, Antigen, Antiserum, And Control
Device Class
Class II
Regulation Number
866.5270
Review Panel
IM
Submission Type